Descemet stripping endothelial keratoplasty in pediatric patients with congenital hereditary endothelial dystrophy
American Journal of Ophthalmology Nov 08, 2019
Yang F, Hong J, Xiao G, et al. - Researchers assessed a retrospective case series of pediatric patients with congenital hereditary endothelial dystrophy (CHED) who underwent Descemet stripping endothelial keratoplasty (DSEK) in order to report the long-term outcomes of DSEK with suture-assisted donor lenticule insertion performed in different age groups for pediatric patients with CHED. They included 30 eyes of 16 patients: 19 eyes (10 patients) in the child group and 11 eyes (6 patients) in the infant group. The infant group exhibited better average postoperative best-corrected visual acuity (BCVA) (logMAR 0.32 ± 0.11) than that observed in the child group (logMAR 0.54 ± 0.20. Postoperative BCVA was achieved or was better than logMAR 0.4 in 33% of cases in the child group and 86% of cases in the infant group. The child group had average endothelial cell loss of 31.21% ± 9.17%. These findings suggest that in infant patients with CHED, improved visual outcomes could be achieved after DSEK without significant complications. Advocated technical points are suture-assisted donor lenticule insertion techniques, Descemet membrane stripping, and postoperative sedation.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries